40803 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 09
14:58 UTC
|
APH
Amphenol
|
◎ Target | Joseph Giordano ★★★☆☆ #1124 | Hold | $175.00→ $90.00-48.6% |
|
Sep 09
14:58 UTC
|
APD
Air Products and Chemicals
|
◎ Target | Alexandra Yates ★★★★★ #235 | Buy | $316.00→ $329.00+4.1% |
|
Sep 09
13:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | Daniel Jester ★★★★★ #96 | Outperform | $103.00→ $90.00-12.6% |
|
Sep 09
13:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | Joe Vruwink not yet tracked | Outperform | $101.00→ $85.00-15.8% |
|
Sep 09
13:58 UTC
|
SFD
Smithfield Foods
|
◎ Target | Benjamin Theurer ★★★☆☆ #1182 | Overweight | $31.00→ $29.00-6.5% |
|
Sep 09
13:58 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Yatin Suneja ★★☆☆☆ #2892 | Buy | $42.00→ $46.00+9.5% |
|
Sep 09
13:58 UTC
|
PHVS
Pharvaris
|
◎ Target | Jonathan Wolleben ★★☆☆☆ #2529 | Market Outperform | $75.00→ $79.00+5.3% |
|
Sep 09
13:58 UTC
|
PHVS
Pharvaris
|
◎ Target | Nevin Varghese not yet tracked | Outperform | $52.00→ $62.00+19.2% |
|
Sep 09
13:58 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Eliana Merle ★★★☆☆ #1338 | Overweight | $90.00→ $85.00-5.6% |
|
Sep 09
13:58 UTC
|
IDYA
IDEAYA Biosciences
|
◎ Target | Paul Jeng ★☆☆☆☆ #3131 | Buy | $54.00→ $57.00+5.6% |
|
Sep 09
13:58 UTC
|
EVMN
Evommune
|
◎ Target | Brian Abrahams ★★★☆☆ #1940 | Outperform | $29.00→ $21.00-27.6% |
|
Sep 09
13:58 UTC
|
DYN
Dyne Therapeutics
|
◎ Target | Brian Skorney ★★☆☆☆ #2400 | Outperform | $30.00→ $26.00-13.3% |
|
Sep 09
13:58 UTC
|
DYN
Dyne Therapeutics
|
◎ Target | Luca Issi ★★★☆☆ #1566 | Outperform | $35.00→ $30.00-14.3% |
|
Sep 09
13:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Nik Cremo ★★★☆☆ #1456 | Overweight | $33.00→ $40.00+21.2% |
|
Sep 09
13:58 UTC
|
CASY
Casey's General Stores
|
◎ Target | Irene Nattel ★★★☆☆ #1259 | Sec→ r Perform | $913.00→ $910.00-0.3% |
|
Sep 09
13:58 UTC
|
ABM
ABM Industries
|
◎ Target | Andrew Wittmann ★★★★☆ #670 | Neutral | $48.00→ $53.00+10.4% |
|
Sep 09
12:58 UTC
|
VRNS
Varonis Systems
|
◎ Target | Mike Cikos ★★★★★ #18 | Buy | $50.00→ $55.00+10.0% |
|
Sep 09
12:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | Jason Celino ★★★★☆ #431 | Overweight | $120.00→ $110.00-8.3% |
|
Sep 09
12:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | Billy Fitzsimmons ★★★★★ #264 | Overweight | $115.00→ $110.00-4.3% |
|
Sep 09
12:58 UTC
|
TPFG
The Property Franchise Group
|
◎ Target | firm only | Buy | GBX 660→ GBX 640-3.0% |
|
Sep 09
12:58 UTC
|
STEM
SThree
|
◎ Target | firm only | Buy | GBX 260→ GBX 360+38.5% |
|
Sep 09
12:58 UTC
|
PAGE
PageGroup
|
◎ Target | firm only | Buy | GBX 210→ GBX 355+69.0% |
|
Sep 09
12:58 UTC
|
NTLA
Intellia Therapeutics
|
◎ Target | David Nierengarten ★★★☆☆ #2188 | Neutral | $12.00→ $13.00+8.3% |
|
Sep 09
12:58 UTC
|
INNV
InnovAge
|
◎ Target | Matthew Gillmor not yet tracked | Overweight | $13.00→ $14.00+7.7% |
|
Sep 09
12:58 UTC
|
IMAX
IMAX
|
◎ Target | Steve Frankel ★★★☆☆ #2050 | Buy | $60.00→ $65.00+8.3% |
|
Sep 09
12:58 UTC
|
HLN
Haleon
|
◎ Target | firm only | Sell | GBX 335→ GBX 320-4.5% |
|
Sep 09
12:58 UTC
|
HAS
Hays
|
◎ Target | firm only | Buy | GBX 60→ GBX 95+58.3% |
|
Sep 09
12:58 UTC
|
FCH
Funding Circle
|
◎ Target | firm only | Buy | GBX 300→ GBX 308+2.7% |
|
Sep 09
12:58 UTC
|
DNLM
Dunelm Group
|
◎ Target | firm only | Buy | GBX 1,050→ GBX 1,000-4.8% |
|
Sep 09
12:58 UTC
|
CNS
Corero Network Security
|
◎ Target | firm only | Buy | GBX 20→ GBX 21+5.0% |
|
Sep 09
12:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Joseph Vafi ★☆☆☆☆ #3106 | Buy | $45.00→ $50.00+11.1% |
|
Sep 09
12:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Alex Markgraff ★★☆☆☆ #2871 | Overweight | $33.00→ $40.00+21.2% |
|
Sep 09
12:58 UTC
|
CAN
Canaan
|
◎ Target | Kevin Cassidy ★★☆☆☆ #2684 | Buy | $1.30→ $0.75-42.3% |
|
Sep 09
12:58 UTC
|
BSX
Boston Scientific
|
◎ Target | Marie Thibault ★★★★☆ #849 | Buy | $60.00→ $56.00-6.7% |
|
Sep 09
12:58 UTC
|
BRZE
Braze
|
◎ Target | Brett Huff ★★★☆☆ #2140 | Overweight | $31.00→ $34.00+9.7% |
|
Sep 09
09:57 UTC
|
SEPL
Seplat Energy
|
◎ Target | firm only | Buy | GBX 665→ GBX 875+31.6% |
|
Sep 09
09:57 UTC
|
MAB1 Mortgage Advice Bureau
|
◎ Target | firm only | Buy | GBX 1,150→ GBX 975-15.2% |
|
Sep 09
09:57 UTC
|
JSG
Johnson Service Group
|
◎ Target | firm only | Buy | GBX 205→ GBX 200-2.4% |
|
Sep 09
09:57 UTC
|
DNLM
Dunelm Group
|
◎ Target | firm only | Overweight | GBX 1,225→ GBX 1,050-14.3% |
|
Sep 09
09:57 UTC
|
CCC
Computacenter
|
◎ Target | firm only | Buy | GBX 5,300→ GBX 6,500+22.6% |
|
Sep 09
00:56 UTC
|
ZS
Zscaler
|
◎ Target | Fatima Boolani ★★★★★ #92 | Buy | $175.00→ $205.00+17.1% |
|
Sep 09
00:56 UTC
|
XPO
XPO
|
◎ Target | Ariel Rosa ★★★☆☆ #1307 | Neutral | $221.00→ $220.00-0.5% |
|
Sep 09
00:56 UTC
|
VRSK
Verisk Analytics
|
◎ Target | Manav Patnaik ★★★★☆ #739 | Overweight | $275.00→ $225.00-18.2% |
|
Sep 09
00:56 UTC
|
VLY
Valley National Bancorp
|
◎ Target | Manan Gosalia ★★★★☆ #851 | Equal Weight | $16.00→ $17.00+6.2% |
|
Sep 09
00:56 UTC
|
VLO
Valero Energy
|
◎ Target | Manav Gupta ★★★★☆ #364 | Buy | $355.00→ $450.00+26.8% |
|
Sep 09
00:56 UTC
|
VERA
Vera Therapeutics
|
◎ Target | Anupam Rama ★★☆☆☆ #2704 | Overweight | $76.00→ $83.00+9.2% |
|
Sep 09
00:56 UTC
|
UMBF
UMB Financial
|
◎ Target | Brian Wilczynski ★★★★☆ #846 | Overweight | $159.00→ $190.00+19.5% |
|
Sep 09
00:56 UTC
|
UDR
United Dominion Realty Trust
|
◎ Target | Vikram Malhorta not yet tracked | Neutral | $41.00→ $39.00-4.9% |
|
Sep 09
00:56 UTC
|
TRI
Thomson Reuters
|
◎ Target | Manav Patnaik ★★★★☆ #739 | Overweight | $140.00→ $130.00-7.1% |
|
Sep 09
00:56 UTC
|
TH
Target Hospitality
|
◎ Target | Scott Schneeberger ★★★☆☆ #1973 | Outperform | $24.00→ $27.00+12.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.